{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:16:14Z","timestamp":1764332174070},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,25]],"date-time":"2013-04-25T00:00:00Z","timestamp":1366848000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0002183","type":"journal-article","created":{"date-parts":[[2013,4,25]],"date-time":"2013-04-25T20:55:24Z","timestamp":1366923324000},"page":"e2183","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":89,"title":["Phage Therapy Is Effective against Infection by Mycobacterium ulcerans in a Murine Footpad Model"],"prefix":"10.1371","volume":"7","author":[{"given":"Gabriela","family":"Trigo","sequence":"first","affiliation":[]},{"given":"Teresa G.","family":"Martins","sequence":"additional","affiliation":[]},{"given":"Alexandra G.","family":"Fraga","sequence":"additional","affiliation":[]},{"given":"Adhemar","family":"Longatto-Filho","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio G.","family":"Castro","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Azeredo","sequence":"additional","affiliation":[]},{"given":"Jorge","family":"Pedrosa","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2013,4,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.clindermatol.2008.09.021","article-title":"Buruli ulcer","volume":"27","author":"F Portaels","year":"2009","journal-title":"Clin Dermatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.det.2010.09.006","article-title":"Buruli ulcer: Advances in understanding <italic>Mycobacterium ulcerans<\/italic> infection","volume":"29","author":"DS Walsh","year":"2011","journal-title":"Dermatol Clin"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/cbic.200400339","article-title":"A novel mycolactone from a clinical isolate of <italic>Mycobacterium ulcerans<\/italic> provides evidence for additional toxin heterogeneity as a result of specific changes in the modular polyketide synthase","volume":"6","author":"H Hong","year":"2005","journal-title":"Chem Bio Chem"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1128\/IAI.68.2.877-883.2000","article-title":"A <italic>Mycobacterium ulcerans<\/italic> toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells","volume":"68","author":"KM George","year":"2000","journal-title":"Infect Immun"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1126\/science.283.5403.854","article-title":"Mycolactone: a polyketide toxin from <italic>Mycobacterium ulcerans<\/italic> required for virulence","volume":"283","author":"KM George","year":"1999","journal-title":"Science"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"947","DOI":"10.4049\/jimmunol.0902717","article-title":"IFN-<italic>\u03b3<\/italic>-dependent activation of macrophages during experimental infections by <italic>Mycobacterium ulcerans<\/italic> is impaired by the toxin mycolactone","volume":"184","author":"E Torrado","year":"2010","journal-title":"J Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1128\/IAI.00290-07","article-title":"Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with <italic>Mycobacterium ulcerans<\/italic> has implications for the control of infection","volume":"75","author":"E Torrado","year":"2007","journal-title":"Infect Immun"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1128\/AEM.68.9.4623-4628.2002","article-title":"Aquatic insects as a vector for <italic>Mycobacterium ulcerans<\/italic>","volume":"68","author":"L Marsollier","year":"2002","journal-title":"Appl Environ Microbiol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1371\/journal.pntd.0000178","article-title":"First cultivation and characterization of <italic>Mycobacterium ulcerans<\/italic> from the environment","volume":"2","author":"F Portaels","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S1473-3099(09)70234-8","article-title":"Pathogenetic mechanisms of the intracellular parasite <italic>Mycobacterium ulcerans<\/italic> leading to Buruli ulcer","volume":"9","author":"MT Silva","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"ref11","first-page":"10","article-title":"Provisional guidance on the role of specific antibiotics in the management of <italic>Mycobacterium ulcerans<\/italic> disease (Buruli ulcer)","year":"2004","journal-title":"WHO\/CDS\/CPE\/GBUI\/2004"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e736","DOI":"10.1371\/journal.pntd.0000736","article-title":"Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (<italic>Mycobacterium ulcerans<\/italic> disease)","volume":"4","author":"K Kibadi","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0140-6736(09)61962-0","article-title":"Antimicrobial treatment for early, limited <italic>Mycobacterium ulcerans<\/italic> infection: a randomised controlled trial","volume":"375","author":"WA Nienhuis","year":"2010","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1128\/AAC.00299-10","article-title":"Clinical Efficacy of combination of rifampin and streptomycin for treatment of <italic>Mycobacterium ulcerans<\/italic> disease","volume":"54","author":"FS Sarfo","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e1252","DOI":"10.1371\/journal.pntd.0001252","article-title":"Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection?","volume":"5","author":"MT Ruf","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4269\/ajtmh.2010.09-0617","article-title":"Severe multifocal form of Buruli Ulcer after streptomycin and rifampin treatment: comments on possible dissemination mechanisms","volume":"83","author":"GE Sopoh","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"564","DOI":"10.5694\/j.1326-5377.2009.tb03313.x","article-title":"\u201c\u2018Paradoxical\u2019\u201d immune-mediated reactions to <italic>Mycobacterium ulcerans<\/italic> during antibiotic treatment: a result of treatment success, not failure","volume":"191","author":"DP O'Brien","year":"2009","journal-title":"Med J Aust"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e770","DOI":"10.1371\/journal.pntd.0000770","article-title":"All-oral antibiotic treatment for Buruli Ulcer: a report of four patients","volume":"4","author":"CL Gordon","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4161\/bact.1.2.15845","article-title":"Phage treatment of human infections","volume":"1","author":"ST Abedon","year":"2011","journal-title":"Bacteriophage"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1054\/mehy.2001.1522","article-title":"Treatment of post-burns bacterial infections by bacteriophages, specifically ubiquitous <italic>Pseudomonas spp.<\/italic> notoriously resistant to antibiotics","volume":"58","author":"SI Ahmad","year":"2002","journal-title":"Med Hypoth"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1128\/IAI.70.1.204-210.2002","article-title":"Bacteriophage Therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant <italic>Enterococcus faecium<\/italic>","volume":"70(1)","author":"B Biswas","year":"2002","journal-title":"Infect immun"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1128\/AAC.01513-06","article-title":"Experimental phage therapy against <italic>Staphylococcus aureus<\/italic> in mice","volume":"51","author":"R Capparelli","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00284-009-9430-y","article-title":"Characterization of a T7-like lytic bacteriophage of <italic>Klebsiella pneumoniae<\/italic> B5055: a potential therapeutic agent","volume":"59","author":"V Verma","year":"2009","journal-title":"Curr Microbiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1128\/AAC.01028-06","article-title":"Phage therapy of <italic>Pseudomonas aeruginosa<\/italic> infection in a mouse burn wound model","volume":"51","author":"CS McVay","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1128\/AAC.01123-10","article-title":"Experimental Phage Therapy in treating <italic>Klebsiella pneumoniae<\/italic>-mediated liver abscesses and bacteremia in mice","volume":"55","author":"CH Hung","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1128\/AAC.49.3.1220-1221.2005","article-title":"Experimental bacteriophage protection against <italic>Staphylococcus aureus<\/italic> abscesses in a rabbit model","volume":"49","author":"QF Wills","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref27","first-page":"547","article-title":"Bacteriophage therapy of bacterial infections: an update of our institute&apos;s experience","volume":"48","author":"B Weber-Dabrowska","year":"2000","journal-title":"Arch Immunol Ther Ex"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2230.2004.01600.x","article-title":"The use of a novel biodegradable preparation capable of the sustained release of bacteriophages and ciprofloxacin , in the complex treatment of multidrug-resistant <italic>Staphylococcus aureus<\/italic>-infected local radiation injuries caused by exposure to Sr90","volume":"30","author":"D Jikia","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/CDLI.5.3.294-298.1998","article-title":"Use of Lytic Bacteriophage for control of experimental <italic>Escherichia coli<\/italic> septicemia and meningitis in chickens and calves","volume":"5","author":"P Barrow","year":"1998","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.vetmic.2010.05.015","article-title":"<italic>In vivo<\/italic> efficiency evaluation of a phage cocktail in controlling severe colibacillosis in confined conditions and experimental poultry houses","volume":"146","author":"A Oliveira","year":"2010","journal-title":"Vet Microbiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1749-4486.2009.01973.x","article-title":"A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic resistant <italic>Pseudomonas aeruginosa<\/italic>: a preliminary report of efficacy","volume":"34","author":"A Wright","year":"2009","journal-title":"Clin Otolaryngol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1128\/IAI.71.2.774-783.2003","article-title":"Heterogeneity of mycolactones produced by clinical isolates of <italic>Mycobacterium ulcerans<\/italic>: implications for virulence","volume":"71","author":"A Mve-Obiang","year":"2003","journal-title":"Infect Immun"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1128\/JB.187.5.1668-1676.2005","article-title":"Common evolutionary origin for the unstable virulence plasmid pMUM found in geographically diverse strains of <italic>Mycobacterium ulcerans<\/italic>","volume":"187","author":"TP Stinear","year":"2005","journal-title":"J Bacteriol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1128\/IAI.73.10.6299-6310.2005","article-title":"Infection with <italic>Mycobacterium ulcerans<\/italic> induces persistent inflammatory responses in mice","volume":"73","author":"MS Oliveira","year":"2005","journal-title":"Infect Immun"},{"key":"ref35","unstructured":"Sambrook J, Russel DW (2001) Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press."},{"key":"ref36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1099\/jmm.0.46238-0","article-title":"Host range of 14 mycobacteriophages in <italic>Mycobacterium ulcerans<\/italic> and seven other mycobacteria including <italic>Mycobacterium tuberculosis<\/italic>\u2013application for identification and susceptibility testing","volume":"55","author":"J Rybniker","year":"2006","journal-title":"J Med Microbiol"},{"key":"ref37","first-page":"78","article-title":"A method for counting acid-fast bacteria","volume":"36","author":"CC Shepard","year":"1968","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1128\/IAI.00820-10","article-title":"<italic>Mycobacterium ulcerans<\/italic> triggers T-cell immunity followed by local and regional but not systemic immunosuppression","volume":"79","author":"AG Fraga","year":"2011","journal-title":"Infec Immun"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e32740","DOI":"10.1371\/journal.pone.0032740","article-title":"Local and regional re-establishment of cellular immunity during curative antibiotherapy of murine <italic>Mycobacterium ulcerans<\/italic> infection","volume":"7","author":"TG Martins","year":"2012","journal-title":"PLoS One"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e33406","DOI":"10.1371\/journal.pone.0033406","article-title":"Cellular immunity confers transient protection in experimental Buruli Ulcer following BCG or mycolactone-negative <italic>Mycobacterium ulcerans<\/italic> vaccination","volume":"7","author":"AG Fraga","year":"2012","journal-title":"PLoS 0ne"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Calendar RL, Abedon ST (2006) The Bacteriophages. New York: Oxford University Press.","DOI":"10.1093\/oso\/9780195148503.001.0001"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2672.2004.02422.x","article-title":"Bacteriophage penetration in vertebrates","volume":"98","author":"K Dabrowska","year":"2005","journal-title":"J Appl Microbiol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/IAI.00889-06","article-title":"Evidence for an intramacrophage growth phase of <italic>Mycobacterium ulcerans<\/italic>","volume":"75","author":"E Torrado","year":"2007","journal-title":"Infect Immun"},{"key":"ref44","first-page":"118","article-title":"Buruli Ulcer, <italic>Mycobacterium ulcerans<\/italic> infection","volume":"1","author":"K Asiedu","year":"2000","journal-title":"World Health Organization WHO\/CDS\/CPE\/GBUI\/2000"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1128\/AAC.49.7.2874-2878.2005","article-title":"Human Volunteers Receiving <italic>Escherichia coli<\/italic> phage T4 orally: a safety test of phage therapy","volume":"49","author":"A Bruttin","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2672.2005.02596.x","article-title":"Mycobacteriophage and their application to disease control","volume":"99","author":"R McNerney","year":"2005","journal-title":"J Appl Microbiol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1073\/pnas.93.8.3188","article-title":"Long-circulating bacteriophage as antibacterial agents","volume":"93","author":"CR Merril","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1469-0691.2005.01340.x","article-title":"Selection of an <italic>Escherichia coli<\/italic> O157: H7 bacteriophage for persistence in the circulatory system of mice infected experimentally","volume":"12","author":"R Capparelli","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1128\/JCM.42.5.2115-2120.2004","article-title":"Development of a bacteriophage phage replication assay for diagnosis of pulmonary tuberculosis","volume":"42","author":"R McNerney","year":"2004","journal-title":"J Clin Microbiol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0022-5193(03)00174-7","article-title":"Bacterial debris \u2014 an ecological mechanism for coexistence of bacteria and their viruses","volume":"224","author":"A Rabinovitch","year":"2003","journal-title":"J Theor Biol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1067\/mcp.2000.109520","article-title":"Phage therapy: The peculiar kinetics of self-replicating pharmaceuticals","author":"RJH Payne","year":"2000","journal-title":"Clin Pharmacol Therap"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1007\/s12275-011-1512-4","article-title":"Antibacterial efficacy of lytic <italic>Pseudomonas<\/italic> bacteriophage in normal and neutropenic mice models","volume":"49","author":"BR Tiwari","year":"2011","journal-title":"J Microbiol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.1128\/AEM.71.11.6554-6563.2005","article-title":"Bacteriophage therapy to reduce <italic>Campylobacter jejuni<\/italic> colonization of broiler chickens","volume":"71","author":"C Loc Carrillo","year":"2005","journal-title":"Appl Environ Microbiol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1128\/AAC.45.3.649-659.2001","article-title":"Bacteriophage therapy","volume":"45","author":"A Sulakvelidze","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"ref55","first-page":"86","article-title":"Findings from a Buruli ulcer mouse model study","volume":"39","author":"P Addo","year":"2005","journal-title":"Ghana Med J"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1462-5822.2005.00546.x","article-title":"Modulation of the host immune response by a transient intracellular stage of <italic>Mycobacterium ulcerans<\/italic>: the contribution of endogenous mycolactone toxin","volume":"7","author":"E Coutanceau","year":"2005","journal-title":"Cell Microbiol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1128\/AAC.48.8.3130-3132.2004","article-title":"I<italic>n vitro<\/italic> killing of <italic>Mycobacterium ulcerans<\/italic> by acidified nitrite","volume":"48","author":"R Phillips","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2249.2006.03020.x","article-title":"The local immune response in ulcerative lesions of Buruli disease","volume":"143","author":"AE Kiszewski","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1128\/IAI.72.2.958-965.2004","article-title":"Differential production of systemic and intralesional Gamma Interferon and Interleukin-10 in nodular and ulcerative forms of Buruli disease","volume":"72","author":"G Pr\u00e9vot","year":"2004","journal-title":"Infect Immun"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/jmbi.1997.1610","article-title":"Genome structure of mycobacteriophage D29: implications for phage evolution","volume":"279","author":"ME Ford","year":"1998","journal-title":"J Mol Biol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ijmm.2010.04.002","article-title":"Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens","volume":"300","author":"VA Fischetti","year":"2010","journal-title":"Int J Med Microbiol"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0002183","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T13:54:16Z","timestamp":1715262856000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0002183"}},"subtitle":[],"editor":[{"given":"Christian","family":"Johnson","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2013,4,25]]},"references-count":61,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0002183","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,25]]}}}